What is the forecast for ELV stock in 2026?
Elevance Health, Inc. (ELV) equity forecasts constructed by healthcare sector analysts incorporate multi-year operational projections across managed care and commercial health insurance segments. Valuation models evaluate membership enrollment dynamics within Medicaid and Medicare platforms, medical cost ratio management, pharmacy benefit services expansion, and disciplined capital allocation strategies supporting long-term earnings growth.
Related FAQs
Elevance Health (ELV) is currently viewed favorably by market analysts, holding a consensus rating of "Buy". This positive outlook is supported by insights from a significant number of analysts who cover the company.
Executive compensation for the chief executive leadership guiding Entain plc (a major global sports betting, gaming, and interactive entertainment enterprise) reflects international corporate governance benchmarks.
Yes, Elevance Health is the same company as the former Anthem, Inc. The company officially rebranded from Anthem, Inc.
Yes, Elysian Bank offers a comprehensive mobile banking application that allows customers to manage their finances securely from their smartphones.
Gail Boudreaux resides in the United States, maintaining her primary household close to the corporate executive offices of Elevance Health, where she serves as the chief executive officer.
Determining whether Elevance Health is a "good" investment depends on an investor’s portfolio objectives, as the stock is often viewed as a stable, large-cap utility-like play in the healthcare sector.
The ticker symbol ELV historically represented Elevance Health, Inc. before its ticker transition, or relates to specific global securities.
Equity research analysts tracking Elevance Health, Inc. (ELV) maintain a consensus Buy rating, with average 12-month price targets clustering around $439.22 to $443.50 per share, and upper estimates reaching up to $498.00.
Deciding whether to purchase shares of Elevance Health (ELV) requires evaluating its position as a major managed healthcare provider offering health insurance plans, commercial policies, and specialized healthcare services.
Elevance Health, Inc., a massive American health insurance and managed care titan, operated for many decades under the corporate name Anthem, Inc., and prior to that as WellPoint, Inc.
UnitedHealthcare and Anthem are both massive national insurers, and the "better" plan usually depends on the specific network available in your area.
Elevance Health Inc. (ELV) has seen a turbulent summer, with the stock closing July 31, 2026, at $375.84. This followed a peak of over $426 in mid-July, after which the stock experienced a correction.
Elevance Health, Inc. (ELV) operates as a leading health benefits company and independent licensee of the Blue Cross Blue Shield Association, serving tens of millions of managed care members.
Elevance Health, Inc. (formerly known as Anthem, Inc., trading under the ticker ELV) operates as a premier health benefits company in the United States, facing intense competition across managed care and health insurance sectors.